The University of Newcastle has received a record $14 million from the National Health and Medical Research Council (NHMRC).

Funding for 18 research projects, totalling $12.6 million, is an increase of $3.5 million on project funding last year. In addition, the University has received funds for equipment and Research Fellowships.

Deputy Vice-Chancellor (Research), Professor Barney Glover, said the funding was an outstanding result for the University.

"The funding amount is an increase of more than 50 per cent on 2006 and recognises the University as a world leader in health and medical research."

Researchers from five of the University's Priority Research Centres (PRCs) are among the successful recipients.

Professor John Forbes - a world leader in breast cancer research - has received $4.7 million to continue his work. A Professor of Surgical Oncology at the University and Calvary Mater Newcastle, he coordinates the Australian New Zealand Breast Cancer Trials Group and works in collaboration with the Hunter Medical Research Institute's (HMRI) Cancer Research Program.

Professor Paul Foster is Co-Director of the PRC for Asthma and Respiratory Diseases, in collaboration with HMRI's Viruses, Infections/Immunity, Vaccines and Asthma (VIVA) Program. He has received three major grants totalling more than $1.7 million.

There is also funding for research into depression, stroke, reproduction and pregnancy, and drug regulation.

Professor Glover said the funding confirmed the University of Newcastle's standing among the top 10 universities in Australia for research.

"Our research program is aimed at delivering real results which have impact locally, nationally and internationally.

"Our researchers rank among the world's best and these grants will extend the vitally important work they are doing in health and medical research."

The University's Priority Research Centres bring together researchers across health, energy and the environment, and science and engineering. The health-related PRCs work in collaboration with HMRI.